Healthcare: 44 NSE stocks
Data dated 19 Nov 2026 (NSE close) · refreshed every trading day
The Healthcare group has 44 stocks in our NSE end-of-day data, using the industry label NSE assigns to each listed company. On 19 Nov 2026, 31 of them closed higher and 12 closed lower, and the equal-weight average member moved +0.7% on the day. Equal-weight means every stock counts the same, so a small company moves the average as much as the largest one.
Over the last 20 sessions, from the close of 21 Oct 2026 to 19 Nov 2026, the group's equal-weight return was +11.8%, which ranks it 1 of 19 NSE industry groups on 20-session return. Measured against the NIFTY 50 from 21 Oct 2026 to 17 Nov 2026 (the latest index file in the data), the group returned +11.2% against the index's +11.3%, which is 0.0 pp behind the benchmark.
84% of members closed above their own 20-session average price, against 71% for all stocks in our data. That is a simple breadth reading: it says how many members are trading above their recent average, not whether the group will keep moving.
Within the group, the largest 20-session gains were EMCURE (+33.6%), SAILIFE (+28.3%), MAXHEALTH (+26.9%), and the largest declines were CAPLIPOINT (−6.2%), IPCALAB (−3.1%), GRANULES (−0.8%). The spread between them is a reminder that a group average can hide very different stories.
On delivery, the average member's delivery % was 1.05× its own 20-session median today, with 1 delivery spike(s) (at least 1.3× normal delivery on 1.5× volume) and 0 churn day(s) (heavy volume, under 30% delivery).
1 member(s) had a one-day move larger than ±20% in the last 20 sessions, which in raw exchange prices usually means a split or bonus; they are listed but left out of the averages.
Figures are computed automatically from exchange data after the close and refresh every trading day. They describe the group; they are not a recommendation.
Members
| Stock | Close | Day | 20 sessions | Delivery | vs own median | Footprint today |
|---|---|---|---|---|---|---|
| EMCURE Emcure Pharmaceuticals | 2,344.70 | ▲ up +0.4% | ▲ up +33.6% | 58% | 1.0× | none |
| SAILIFE Sai Life Sciences | 1,788.40 | flat 0.0% | ▲ up +28.3% | 42% | 0.9× | none |
| MAXHEALTH Max Healthcare Institute | 1,040.65 | ▲ up +1.7% | ▲ up +26.9% | 64% | 1.2× | option-writing shift; price up, futures OI down |
| ACUTAAS Acutaas Chemicals | 3,977.10 | ▼ down −0.4% | ▲ up +26.2% | 59% | 1.2× | none |
| PPLPHARMA Piramal Pharma | 239.65 | ▲ up +0.3% | ▲ up +25.4% | 47% | 1.2× | none |
| DIVISLAB Divi's Laboratories | 11,178.00 | ▲ up +1.2% | ▲ up +21.6% | 66% | 1.1× | option-writing shift; price up, futures OI up |
| MEDANTA Global Health | 1,478.30 | ▲ up +2.9% | ▲ up +20.0% | 65% | 1.1× | none |
| RUBICON Rubicon Research | 1,722.30 | ▲ up +3.9% | ▲ up +18.9% | 58% | 1.2× | none |
| GLENMARK Glenmark Pharmaceuticals | 2,608.50 | ▼ down −1.4% | ▲ up +18.9% | 49% | 1.1× | option-writing shift |
| ONESOURCE Onesource Specialty Pharma | 1,602.90 | ▲ up +1.1% | ▲ up +18.1% | 48% | 1.0× | none |
| WOCKPHARMA Wockhardt | 2,187.00 | ▲ up +7.9% | ▲ up +16.5% | 31% | 0.8× | none |
| ANTHEM Anthem Biosciences | 936.80 | ▲ up +2.5% | ▲ up +16.3% | 46% | 0.9× | none |
| SYNGENE Syngene International | 437.35 | ▲ up +0.6% | ▲ up +16.2% | 49% | 0.9× | none |
| MANKIND Mankind Pharma | 2,629.00 | ▲ up +0.1% | ▲ up +15.0% | 52% | 1.0× | option-writing shift |
| APOLLOHOSP Apollo Hospitals Enterprise | 8,738.00 | ▼ down −0.9% | ▲ up +15.0% | 52% | 0.9× | price down, futures OI up |
| LAURUSLABS Laurus Labs | 2,306.00 | ▼ down −0.7% | ▲ up +14.6% | 55% | 1.2× | option-writing shift |
| AUROPHARMA Aurobindo Pharma | 1,805.70 | ▲ up +0.5% | ▲ up +14.4% | 64% | 1.2× | none |
| KIMS Krishna Institute of Medical Sciences | 767.80 | ▲ up +1.2% | ▲ up +13.9% | 50% | 1.0× | none |
| ASTERDM Aster DM Quality Care | 739.30 | ▲ up +1.1% | ▲ up +13.7% | 57% | 1.0× | none |
| POLYMED Poly Medicure | 1,670.60 | ▲ up +1.0% | ▲ up +13.6% | 56% | 1.1× | none |
| DRREDDY Dr. Reddy's Laboratories | 1,400.90 | ▲ up +0.2% | ▲ up +12.6% | 57% | 1.1× | option-writing shift |
| GLAND Gland Pharma | 3,292.90 | ▲ up +1.9% | ▲ up +12.2% | 54% | 1.0× | none |
| VIJAYA Vijaya Diagnostic Centre | 1,510.60 | ▼ down −1.5% | ▲ up +11.6% | 26% | 0.6× | none |
| NEULANDLAB Neuland Laboratories | 21,102.00 | ▼ down −1.7% | ▲ up +11.2% | 52% | 1.1× | none |
| FORTIS Fortis Healthcare | 809.85 | ▲ up +2.1% | ▲ up +11.1% | 53% | 1.0× | price up, futures OI down |
| GLAXO Glaxosmithkline Pharmaceuticals | 2,713.40 | ▲ up +2.9% | ▲ up +10.1% | 55% | 0.9× | none |
| SUNPHARMA Sun Pharmaceutical Industries | 1,900.00 | ▲ up +1.5% | ▲ up +8.9% | 53% | 0.9× | option-writing shift |
| NH Narayana Hrudayalaya | 1,873.10 | ▼ down −1.0% | ▲ up +8.6% | 57% | 1.0× | none |
| BIOCON Biocon | 363.65 | ▲ up +0.5% | ▲ up +8.6% | 53% | 1.1× | none |
| CIPLA Cipla | 1,418.50 | ▲ up +0.1% | ▲ up +8.0% | 56% | 0.9× | option-writing shift |
| ZYDUSLIFE Zydus Lifesciences | 1,202.90 | ▲ up +0.1% | ▲ up +7.7% | 70% | 1.3× | option-writing shift |
| LALPATHLAB Dr. Lal Path Labs | 1,963.20 | ▼ down −0.1% | ▲ up +6.9% | 61% | 1.0× | none |
| NATCOPHARM NATCO Pharma | 821.95 | ▲ up +0.2% | ▲ up +4.8% | 51% | 0.9× | none |
| RAINBOW Rainbow Childrens Medicare | 1,240.80 | ▼ down −1.4% | ▲ up +2.6% | 72% | 1.3× | delivery spike, down candle |
| ALKEM Alkem Laboratories | 5,145.00 | ▼ down −1.5% | ▲ up +2.6% | 41% | 0.9× | option-writing shift; price down, futures OI down |
| LUPIN Lupin | 1,998.80 | ▲ up +1.4% | ▲ up +1.8% | 59% | 1.1× | option-writing shift |
| TORNTPHARM Torrent Pharmaceuticals | 4,611.00 | flat 0.0% | ▲ up +1.3% | 63% | 1.0× | option-writing shift |
| AJANTPHARM Ajanta Pharmaceuticals | 3,270.30 | ▼ down −0.1% | ▲ up +0.3% | 71% | 1.2× | none |
| ABBOTINDIA Abbott India | 25,695.00 | ▲ up +0.9% | ▲ up +0.1% | 64% | 1.2× | none |
| COHANCE Cohance Lifesciences | 459.45 | ▲ up +0.7% | ▼ down −0.5% | 48% | 1.3× | none |
| GRANULES Granules India | 801.20 | ▲ up +0.5% | ▼ down −0.8% | 62% | 1.3× | none |
| IPCALAB Ipca Laboratories | 1,860.00 | ▲ up +0.3% | ▼ down −3.1% | 69% | 1.3× | none |
| CAPLIPOINT Caplin Point Laboratories | 2,084.60 | flat 0.0% | ▼ down −6.2% | 32% | 0.7× | none |
| CONCORDBIO Concord Biotech | 556.40 | ▼ down −0.8% | excluded* | 58% | 1.4× | none |
Sorted by 20-session return. "vs own median" = today's delivery % ÷ the stock's median of the previous 20 sessions. Footprint labels come from our footprint engine and describe today's data only. * One-day move larger than ±20% in the last 20 sessions (probable split or bonus in raw prices): excluded from averages.
Source: NSE bhavcopy (prices, volume, delivery), NSE provisional FII/DII cash data and NSE F&O bhavcopy, via the tietiy data store (TDT). Benchmark: NIFTY 50, 21 Oct 2026 to 17 Nov 2026. Descriptive context, not investment advice.
Get the market on WhatsApp
The Stock in Focus and the evening Wrap, as one clear card. Free. 1 to 3 posts a day. Leave any time.